Interleukin-6 affects melphalan-induced DNA damage and repair in human multiple myeloma cells

Anticancer Research

Volumn 22, Issue 1 A, 2002, Pages 231-234

  Efferth, Thomas ^a   Fabry, Ursula ^a   Osieka, Rainhardt ^a  

^a Virtueller Campus Rheinland Pfalz ^*  (Germany)

Author keywords

Apoptosis; Drug resistance; PCR stop assay

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GROWTH FACTOR; INTERLEUKIN 6; MELPHALAN;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DRUG RESISTANCE; FLOW CYTOMETRY; HEMATOPOIETIC SYSTEM TUMOR; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MYELOMA CELL; PARACRINE SIGNALING; PLASMA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STROMA CELL;

AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; DNA DAMAGE; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; FLOW CYTOMETRY; GLUCOSEPHOSPHATE DEHYDROGENASE; HUMANS; INTERLEUKIN-6; MELPHALAN; MULTIPLE MYELOMA; PLASMA CELLS; POLYMERASE CHAIN REACTION;

EID: 0036244609     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Interleukin-6 inhibits apoptosis of malignant plasma cells
2. Protection of human myeloid leukemic cells against doxorubicin induced apoptosis by granulocyte-macrophage colony stimulating factor and interleukin 3
3. Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells
4. Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia
5. Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma
6. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
7. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma
8. Gene-specific damage produced by cisplatinum, ormaplatin and UV light in human cells as assayed by the polymerase chain reaction
9. Rapid polymerase chain reaction assay to detect variation in the extent of gene-specific damage between cisplatin- or VP-16-resistant and sensitive lung cancer cell lines
10. A polymerase chain reaction-based method to detect cisplatin adducts in specific genes
11. Sample preparation from blood, cells, and other fluids
12. Molecular study of eight Japanese cases of glucose-6-phosphate dehydrogenase deficiency by nonradioisotopic single-strand conformation polymorphism analyses
13. Features of apoptotic cells measured by flow cytometry
14. Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry
15. Apoptosis and resistance to daunorubicin in human leukemic cells
16. UICC study group on basic and clinical cancer research: Apoptosis in normal and tumour cells
17. DNA repair in cisplatin-sensitive and -resistant human cell lines measured in specific genes by quantitative polymerase chain reaction
18. DNA repair capacity and cisplatin, sensitivity of human testis tumour cells
19. Endogenous interleukin 6 is a resistance factor for cis-diamminedichlorodiplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines
20. Sensitization of human renal cell carcinoma cells to cis-diamminedichloro-platinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody
21. Hematopoetic cytokines inhibit apoptosis induced by transforming growth factor B1 and cancer chemotherapy compounds in myeloid leukemic cells
22. Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL
23. Interleukin-6-induced inhibition of multiple myeloma cell apoptosis: Support for the hypothesis that protection is mediated via inhibition of the JNK/STAT pathway